(S (S (VP (VBG Predicting) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (DT a) (NN drug))) (PP (IN for) (NP (DT a) (VBN given) (NN individual)))) (, ,) (S (VP (VBG using) (NP (JJ high-dimensional) (JJ genomic) (NNS measurements)))) (, ,))) (VP (VBZ is) (PP (IN at) (NP (NP (DT the) (NN core)) (PP (IN of) (NP (NN precision) (NN medicine)))))) (. .))
(S (ADVP (RB However)) (, ,) (S (VP (VBG identifying) (NP (NP (NNS features)) (SBAR (WHPP (IN on) (WHNP (WDT which))) (S (VP (TO to) (VP (VB base) (NP (DT the) (NNS predictions))))))))) (VP (VBZ remains) (NP (DT a) (NN challenge)) (, ,) (SBAR (ADVP (RB especially)) (WRB when) (S (NP (DT the) (NN sample) (NN size)) (VP (VBZ is) (ADJP (JJ small)))))) (. .))
(S (S (S (VP (VBG Incorporating) (NP (NN expert) (NN knowledge)))) (VP (VBZ offers) (NP (NP (DT a) (JJ promising) (NN alternative)) (SBAR (S (VP (TO to) (VP (VB improve) (NP (DT a) (NN prediction) (NN model))))))))) (, ,) (CC but) (S (S (VP (VBG collecting) (NP (JJ such) (NN knowledge)))) (VP (VBZ is) (ADJP (JJ laborious)) (PP (TO to) (NP (DT the) (NN expert))) (SBAR (IN if) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN candidate) (NNS features)))) (VP (VBZ is) (ADJP (RB very) (JJ large))))))) (. .))
(S (NP (PRP We)) (VP (VBP introduce) (NP (NP (DT a) (JJ probabilistic) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB incorporate) (NP (NP (JJ expert) (NN feedback)) (PP (IN about) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (JJ genomic) (NNS measurements))) (PP (IN on) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (DT a) (NN cancer) (NN cell))) (PP (IN for) (NP (DT a) (VBN given) (NN drug)))))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD present) (NP (NP (CD two) (NNS methods)) (SBAR (S (VP (TO to) (ADVP (RB intelligently)) (VB collect) (NP (DT this) (NN feedback)) (PP (IN from) (NP (DT the) (NN expert))) (, ,) (S (VP (VBG using) (NP (NP (JJ experimental) (NN design)) (CC and) (NP (JJ multi-armed) (NN bandit) (NNS models)))))))))) (. .))
(S (PP (IN In) (NP (NP (DT a) (JJ multiple) (NN myeloma) (NN blood) (NN cancer) (NNS data) (NN set)) (PRN (-LRB- -LRB-) (NP (JJ n=51)) (-RRB- -RRB-)))) (, ,) (NP (JJ expert) (NN knowledge)) (VP (VBD decreased) (NP (DT the) (NN prediction) (NN error)) (PP (IN by) (NP (CD 8) (NN %)))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (DT the) (JJ intelligent) (NNS approaches)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (NN workload)) (PP (IN of) (NP (NN feedback) (NN collection)))) (PP (TO to) (NP (QP (JJR less) (IN than) (CD 30)) (NN %)) (PP (IN on) (NP (NN average)))) (PP (VBN compared) (PP (TO to) (NP (DT a) (JJ naive) (NN approach)))))))))) (. .))
